Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avelumab with Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT03299660Phase 2Completed
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Apr 2018
- Primary completion
- Feb 2023
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avelumab in rectal cancer, sponsored by Peter MacCallum Cancer Centre. Started Apr 2018; status: completed.
02
Drugs
avelumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03299660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03299660.